Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)
  7. Department of Pathology and Laboratory Medicine (416)
  8. Gastrointestinal Oncology Service (387)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: A cern clinical trial
    Meeting Abstract

    Gilbert, M.; Yuan, Y.; Wani, K.; Wu, J. M.; Omuro, A.; Lieberman, F.; Robins, H. I.; Gerstner, E.; Wu, J.; Wen, P.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase I/II clinical trial using trans sodium crocetinate as a radiosensitizer for glioblastoma
    Meeting Abstract

    Gainer, J.; Sheehan, J.; Larner, J.; Jones, D.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Patterns of salvage treatment for high grade glioma in the temozolomide era
    Meeting Abstract

    Escorcia, F. E.; Folkert, M. R.; Spratt, D. E.; Zumsteg, Z.; Chan, T.; Omuro, A. M.; Beal, K.; Gutin, P. H.; Yamada, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • TERT promoter mutation, IDH mutation and 1p/19q codeletion define five glioma molecular groups with specific clinical characteristics and germline variant associations
    Meeting Abstract

    Eckel-Passow, J.; LaChance, D.; Walsh, K.; Decker, P.; Sicotte, H.; Pekmezci, M.; Molinaro, A.; Rice, T.; Kosel, M.; Smirnov, I.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Polymorphisms in the COMT, BDNF and DTNBP1 genes and cognitive functions in patients with brain tumors
    Meeting Abstract

    Correa, D.; Satagopan, J.; Baser, R.; Cheung, K.; DeAngelis, L.; Orlow, I.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Genomic characterization of brain metastases reveals branched evolution and metastasis-specific mutations
    Meeting Abstract

    Brastianos, P.; Carter, S.; Santagata, S.; Taylor-Weiner, A.; Jones, R.; Van Allen, E.; Horowitz, P.; Ligon, K.; Cahill, D.; Dunn, I.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Mechanistic investigations of leptomeningeal metastasis from solid tumors
    Meeting Abstract

    Boire, A.; Zou, Y. L.; DeAngelis, L.; Massague, J.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Mebendazole is efficacious in diverse medulloblastoma tumor models and inhibits tumor angiogenesis
    Meeting Abstract

    Bai, R. Y.; Staedtke, V.; Rudin, C.; Bunz, F.; Riggins, G.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of lapatinib and dose-dense temozolomide (TMZ) for adults with recurrent ependymoma: Patient reported putcomes (PRO) from a CERN clinical trial
    Meeting Abstract

    Armstrong, T. S.; Vera-Bolanos, E.; Gilbert, M.; Yuan, Y.; Wani, K.; Wu, J. M.; Omuro, A.; Lieberman, F.; Robins, H. I.; Gerstner, E.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • A phase 3 randomized, open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator's choice chemotherapy (ICC) in patients with advanced melanoma after prior anti-CTLA-4 therapy
    Meeting Abstract

    Weber, J. S.; Minor, D. R.; D'Angelo, S. P.; Hodi, F. S.; Gutzmer, R.; Neyns, B.; Hoeller, C.; Khushalani, N. I.; Miller, W. H.; Grob, J. J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save